TY - CONF T1 - Clinically meaningful responses achieved with tralokinumab in adults with moderate-to-severe atopic dermatitis who did not meet IGA 0/1 at initial 16-week treatment JO - JOURNAL OF INVESTIGATIVE DERMATOLOGY PY - 2022/01/01 AU - Simpson E AU - Blauvelt A AU - Silverberg JI AU - Cork M AU - Katoh N AU - Mark T AU - Schneider S AU - Wollenberg A ED - VL - 142 IS - 8 SP - B17 EP - B17 Y2 - 2025/09/19 ER -